EISAI UNSPONSORED ADR EBIT

The latest EBIT for ESAIY is $-1.6B as of December 2022. That compares with $72B in the prior-year period — down 102.2% year over year. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside EISAI UNSPONSORED ADR's historical trend and sector peers before judging valuation or financial health.

Over the past year, ESAIY's EBIT moved from $72B to $-1.6B — a 102.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in EISAI UNSPONSORED ADR's operating scale or balance-sheet position.

Against Healthcare companies, ESAIY currently prints $-1.6B for EBIT, while the sector average sits near $1.9T. That is roughly 100.1% below the sector mean. Large gaps often invite a closer look at EISAI UNSPONSORED ADR's growth, margins, and balance sheet.

A EBIT figure of $-1.6B for ESAIY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.

After noting ESAIY's EBIT ($-1.6B), review year-over-year change from $72B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.